| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/21/2015 | CN103074302B 抗c肽单克隆抗体及其在检测c肽含量中的用途 Anti-c-peptide monoclonal antibodies and their use in the detection of c-peptide content |
| 01/21/2015 | CN103073641B 在体内具有抗肿瘤活性的抗人Dlk-1抗体 Anti-human in vivo anti-tumor activity of Dlk-1 antibody |
| 01/21/2015 | CN102861327B 一种细胞灭活疫苗、卵黄抗体及卵黄抗体的注射液和冻干粉 A cell inactivated vaccines, antibodies and yolk egg yolk antibody injection and lyophilized powder |
| 01/21/2015 | CN102712695B 能够诱导细胞死亡的ror1生物抑制剂 Able to induce cell death ror1 biological inhibitors |
| 01/21/2015 | CN102369215B 包含全长抗体和单链Fab片段的多特异性抗体 Comprising full-length antibodies and single chain Fab fragment multispecific antibodies |
| 01/21/2015 | CN102124027B 产生富含分泌型免疫球蛋白的乳组分的方法 Produce secretory immunoglobulin-rich milk component method |
| 01/21/2015 | CN102119174B 使用治疗性抗体的组合物和方法 Using the compositions and methods of therapeutic antibodies |
| 01/21/2015 | CN101970494B 人源化抗-C5aR抗体 Humanized anti -C5aR antibody |
| 01/21/2015 | CN101910201B 治疗慢性疲劳综合征的b细胞耗竭剂,如抗-cd20抗体或其片段 Treatment of chronic fatigue syndrome b-cell depleting agent, such as anti-antibody or fragment thereof -cd20 |
| 01/20/2015 | US8937218 Transformed soybean plant which accumulates vaccine, and use thereof |
| 01/20/2015 | US8937165 Proteinic marker for early diagnosis of liver cancer |
| 01/20/2015 | US8937164 Biological materials related to CXCR7 |
| 01/20/2015 | US8937163 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/20/2015 | US8937162 Humanization of rabbit antibodies using a universal antibody framework |
| 01/20/2015 | US8937160 Pharmaceutical composition for treating and/or preventing cancer |
| 01/20/2015 | US8937159 Anti-HER2 antibodies and their uses |
| 01/20/2015 | US8937158 Fc variants with increased affinity for FcγRIIc |
| 01/20/2015 | US8937157 Therapeutic nuclease compositions and methods |
| 01/20/2015 | US8937151 Gelatinase inhibitors and prodrugs |
| 01/20/2015 | US8937150 Anti-viral compounds |
| 01/20/2015 | US8937047 Biokinetics of fast-clearing polypeptides |
| 01/20/2015 | US8936917 KEX2 cleavage regions of recombinant fusion proteins |
| 01/20/2015 | US8936915 Cleavage sensitive antibodies and methods of use thereof |
| 01/20/2015 | US8936785 scFv antibodies which pass epithelial and/or endothelial layers |
| 01/20/2015 | CA2716919C An anti-cd6 monoclonal antibody and use thereof |
| 01/20/2015 | CA2498000C Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 01/15/2015 | WO2015006749A2 Bispecific cd3 and cd19 antigen binding contructs |
| 01/15/2015 | WO2015006744A1 Immunoglobulin fusion proteins and compositions thereof |
| 01/15/2015 | WO2015006723A1 Recurrent gene fusions in cancer |
| 01/15/2015 | WO2015006710A1 Miox antibody and assay |
| 01/15/2015 | WO2015006571A1 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| 01/15/2015 | WO2015006555A2 Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| 01/15/2015 | WO2015006554A1 Therapeutic antibodies and uses thereof |
| 01/15/2015 | WO2015006507A1 Methods of treatment for alzheimer's disease and huntington's disease |
| 01/15/2015 | WO2015006504A1 Anti-complement factor c1q antibodies and uses thereof |
| 01/15/2015 | WO2015006482A1 CERTAIN IMPROVED HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 01/15/2015 | WO2015005961A1 A method of determining virus removal from a sample containing a target protein using activated carbon |
| 01/15/2015 | WO2015005960A1 Removal of fragments from a sample containing a target protein using activated carbon |
| 01/15/2015 | WO2015005747A1 Immunoglobulin fc conjugate maintaining fcrn binding strength |
| 01/15/2015 | WO2015005632A1 Novel dual-targeted protein specifically binding to dll4 and vegf, and use thereof |
| 01/15/2015 | WO2015005479A1 Tumor antigen peptide |
| 01/15/2015 | WO2015004679A1 Improved process for production of monoclonal antibodies |
| 01/15/2015 | WO2015004633A1 Antibodies that recognize islet-amyloid polypeptide (iapp) |
| 01/15/2015 | WO2015004632A1 Antibodies that recognize iapp |
| 01/15/2015 | WO2015004626A2 Use of a vegf antagonist in treating retinopathy of prematurity |
| 01/15/2015 | WO2015004616A1 Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients |
| 01/15/2015 | WO2015004603A1 Anti-pla2r antibody and uses thereof |
| 01/15/2015 | WO2015004473A1 Compounds and methods for treatment or prevention of a pathogen infection |
| 01/15/2015 | WO2015004400A1 Novel antibody-drug conjugates and the use of same in therapy |
| 01/15/2015 | WO2015004181A1 Canine health product containing antibodies against canine parvovirus type 2 |
| 01/15/2015 | WO2015004163A1 Anti-tau monoclonal antibodies |
| 01/15/2015 | WO2015004038A1 ANTIBODIES TO β2-GLYCOPROTEIN I AND THERAPEUTIC USES THEREOF |
| 01/15/2015 | US20150020224 Non-human animals with modified immunoglobulin heavy chain sequences |
| 01/15/2015 | US20150020221 Compositions and Methods for the Modulation of DNA Damage Responses Using BAL1 and BBAP |
| 01/15/2015 | US20150018532 Antibody |
| 01/15/2015 | US20150018531 Anti sez6 antibodies and methods of use |
| 01/15/2015 | US20150018530 Novel Prodrug Containing Molecule Compositions and Their Uses |
| 01/15/2015 | US20150018529 Sequence Symmetric Modified IgG4 Bispecific Antibodies |
| 01/15/2015 | US20150018528 Antibodies That Bind Peptidoglycan Recognition Protein 1 |
| 01/15/2015 | US20150018526 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 01/15/2015 | US20150018516 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer |
| 01/15/2015 | US20150018408 Therapeutic antibodies and uses thereof |
| 01/15/2015 | US20150018323 3b-hydroxysteroid dehydrogenase in steroid-dependent disease |
| 01/15/2015 | US20150018241 Fc-receptor based affinity chromatography |
| 01/15/2015 | US20150018225 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for examining cancer |
| 01/15/2015 | US20150018224 Reagents and methods for detecting protein lysine 2-hydroxyisobutyrylation |
| 01/15/2015 | US20150017738 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
| 01/15/2015 | US20150017699 Internally functionalized graphene substrates |
| 01/15/2015 | US20150017687 Method for obtaining a glycoprotein composition |
| 01/15/2015 | US20150017686 Methods for reducing mannosyltransferase activity in lower eukaryotes |
| 01/15/2015 | US20150017638 Methods for assessing risk for cancer using biomarkers |
| 01/15/2015 | US20150017230 ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
| 01/15/2015 | US20150017200 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/15/2015 | US20150017185 Method to improve the immune function of t cells |
| 01/15/2015 | US20150017184 IL-17 Receptor Antibody Formulation |
| 01/15/2015 | US20150017183 Single domain antibodies as inhibitors of pcsk9 |
| 01/15/2015 | US20150017182 Methods for treating nasal polyposis by administering an il-4r antagonist |
| 01/15/2015 | US20150017181 Prevention of infection |
| 01/15/2015 | US20150017180 Treatment of chronic inflammatory conditions |
| 01/15/2015 | US20150017179 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor |
| 01/15/2015 | US20150017178 Anti-CD26 Antibodies and Uses Thereof |
| 01/15/2015 | US20150017177 Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent |
| 01/15/2015 | US20150017176 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| 01/15/2015 | US20150017175 Methods of administering anti-tnfalpha antibodies |
| 01/15/2015 | US20150017173 Antibodies to human transmembrane proteins |
| 01/15/2015 | US20150017172 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/15/2015 | US20150017171 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 01/15/2015 | US20150017169 Sequence Asymmetric Modified IgG4 Bispecific Antibodies |
| 01/15/2015 | US20150017168 Dual variable domain immunoglobulins and uses thereof |
| 01/15/2015 | US20150017167 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier |
| 01/15/2015 | US20150017166 Regulation of glucose metabolism using anti-cgrp antibodies |
| 01/15/2015 | US20150017165 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF |
| 01/15/2015 | US20150017162 Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same |
| 01/15/2015 | US20150017161 Compositions and methods for the alteration of xlhed phenotypes |
| 01/15/2015 | US20150017157 Methods for treating acne |
| 01/15/2015 | US20150017156 Esx-mediated transcription modulators and related methods |
| 01/15/2015 | US20150017155 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 01/15/2015 | US20150017154 Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 01/15/2015 | US20150017153 Monoclonal antibodies that neutralize anthrax toxins |
| 01/15/2015 | US20150017121 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |